» Articles » PMID: 14688017

Ras Gene Mutations in Patients with Acute Myeloid Leukaemia and Exposure to Chemical Agents

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2003 Dec 23
PMID 14688017
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations of the N- and K-ras genes occur in approximately 15-30% of acute myeloid leukaemia patients. The role of the oncogenic ras in leukaemogenesis remains unclear. Few studies have revealed that mutations in the ras oncogene family are more probably found in acute myeloid leukaemia patients with previous exposure to toxic agents. A case-case study was conducted in the areas of Florence and Turin, Italy, to investigate whether the presence of N- and K-ras mutations in acute myeloid leukaemia patients was related to a higher frequency of exposure to chemicals. During a 3-year period, 111 acute myeloid leukaemia patients were enrolled. All the patients were interviewed using a semi-structured questionnaire collecting data on residential history, occupation, personal habits and pathological history. The presence of N- and K-ras mutations was analysed by amplification and synthetic oligonucleotide probes and by the so-called polymerase chain reaction amplification for specific alleles technique. A total of 34 (30.6%) patients were found to harbour ras mutations in N-ras and/or K-ras. Fourteen patients (12.6%) had a single ras mutation and 20 patients (18%) had two ras mutations. A positive association between a priori at risk jobs and ras mutations was found, based on nine exposed cases; the odds ratio, adjusted by age, sex and previous X-ray and/or chemotherapy was 2.8 (95% confidence intervals: 0.9-9.0). When considering only subjects with two ras mutations the odds ratio was 4.8 (95% confidence intervals: 1.2-18.8). The odds ratio for a previous X-ray and/or chemotherapy was 16.2 (95% confidence intervals: 1.8-755.9); when only subjects with two ras mutations were considered, the odds ratio was 26.1 (95% confidence intervals: 2.5-1248.9). In conclusion, our data suggest that ras oncogene mutations might identify a group of leukaemia in people with previous X-ray/chemotherapy or with exposure to chemical agents in the work environment.

Citing Articles

The Prenatal Origin of Childhood Leukemia: Potential Applications for Epidemiology and Newborn Screening.

Marcotte E, Spector L, Mendes-de-Almeida D, Nelson H Front Pediatr. 2021; 9:639479.

PMID: 33968846 PMC: 8102903. DOI: 10.3389/fped.2021.639479.


Acute myeloid leukaemia at an early age: Reviewing the interaction between pesticide exposure and -rearrangement.

Pombo-de-Oliveira M, Andrade F, Brisson G, Dos Santos Bueno F, Cezar I, Noronha E Ecancermedicalscience. 2017; 11:782.

PMID: 29225689 PMC: 5718248. DOI: 10.3332/ecancer.2017.782.


Tobacco Smoke and Ras Mutations Among Latino and Non-Latino Children with Acute Lymphoblastic Leukemia.

Kaur M, de Smith A, Selvin S, Zhang L, Cunningham M, Kang M Arch Med Res. 2017; 47(8):677-683.

PMID: 28476195 PMC: 5424620. DOI: 10.1016/j.arcmed.2016.11.016.


Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocols.

Singh Z, Jethava Y, Post G, Alapat D, Sawyer J, Waheed S Clin Case Rep. 2015; 3(3):183-92.

PMID: 25838910 PMC: 4377252. DOI: 10.1002/ccr3.180.


RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures.

Andrade F, Furtado-Silva J, de Aguiar Goncalves B, Thuler L, Barbosa T, Emerenciano M BMC Cancer. 2014; 14:133.

PMID: 24571676 PMC: 3946262. DOI: 10.1186/1471-2407-14-133.